Literature DB >> 2781028

Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation.

H S Glazer1, L R Kaiser, D J Anderson, P L Molina, B Emami, C L Roper, S S Sagel.   

Abstract

The computed tomographic (CT) scans of 80 patients with bronchogenic carcinoma classified as indeterminate for direct mediastinal invasion were retrospectively reviewed after the patients had undergone thoracotomy. Forty-eight (60%) of the masses were resectable, without invasion of the mediastinum, 18 (22%) focally invaded the mediastinum but were technically resectable, and 14 (18%) invaded the mediastinum and were not technically resectable. Although in most circumstances in this relatively small subset of patients CT was not helpful in differentiating masses with and without mediastinal invasion, CT was able to separate a large group of masses that were likely to be technically resectable. Thirty-six (97%) of 37 masses with one or more of these CT findings were considered technically resectable: contact of 3 cm or less with mediastinum, less than 90 degrees of contact with aorta, and mediastinal fat between mass and mediastinal structures. Of these 36 masses, 28 were resectable without mediastinal invasion, and eight were resectable with focal limited mediastinal invasion.

Entities:  

Mesh:

Year:  1989        PMID: 2781028     DOI: 10.1148/radiology.173.1.2781028

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

Review 1.  Lung Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Paula Manchon; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

Review 2.  Lung cancer staging: clinical and radiologic perspectives.

Authors:  Sophie Chheang; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

3.  Preoperative computed tomographic scanning for staging lung cancer.

Authors:  P Armstrong
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

4.  Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

Authors:  J de Castro; M Cobo; D Isla; J Puente; N Reguart; B Cabeza; A Gayete; M Sánchez; M I Torres; J Ferreirós
Journal:  Clin Transl Oncol       Date:  2014-11-06       Impact factor: 3.405

Review 5.  Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Authors:  Jessica C Sieren; Yoshiharu Ohno; Hisanobu Koyama; Kazuro Sugimura; Geoffrey McLennan
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

Review 6.  Staging of bronchogenic carcinoma.

Authors:  S J Herman
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

7.  Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours?

Authors:  P G White; H Adams; M D Crane; E G Butchart
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

8.  The clinical feasibility of using non-breath-hold real-time MR-echo imaging for the evaluation of mediastinal and chest wall tumor invasion.

Authors:  Chang Hyun Lee; Jin Mo Goo; Young Tae Kim; Hyun Ju Lee; Chang Min Park; Eun-Ah Park; Ho Yun Lee; Mi-Jin Kang; In Chan Song
Journal:  Korean J Radiol       Date:  2009-12-28       Impact factor: 3.500

Review 9.  Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Authors:  M Reck; F Barlesi; L Crinò; C I Henschke; D Isla; S Stiebeler; D R Spigel
Journal:  Ann Oncol       Date:  2011-11-04       Impact factor: 32.976

10.  Advances in radiological staging of non-small cell lung cancer (NSCLC).

Authors:  S C Rankin
Journal:  Cancer Imaging       Date:  2004-02-14       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.